- Statins are oral medications most commonly prescribed to lower cholesterol. Their anti-inflammatory properties make them of interest for possible use in MS.
- A number of studies are ongoing, primarily in CIS and RRMS. Studies are either alone or in combination with the interferons, Copaxone, or other agents approved for use in MS.
- The effects of statins combined with interferons are controversial and mixed, and additional data are needed to evaluate conflicting results.